Ro48-8684 is a water-soluble
benzodiazepine derivative developed by
Hoffman-LaRoche in the 1990s, which was designed along with
Ro48-6791 as an improved replacement for
midazolam, but ultimately proved to have little advantages over the parent drug and has not been introduced into clinical practice.[1][2]
^Albrecht S, Hering W, Ihmsen H, Schwilden H, Schüttler J (October 1999). "[Pharmacokinetic-pharmacodynamic modeling in phase II of drug development. A comparative study with young and old volunteers with benzdiazepine as an example]". Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie. 34 (10): 634–7.
doi:
10.1055/s-1999-213.
PMID10548960.
Ro48-8684 is a water-soluble
benzodiazepine derivative developed by
Hoffman-LaRoche in the 1990s, which was designed along with
Ro48-6791 as an improved replacement for
midazolam, but ultimately proved to have little advantages over the parent drug and has not been introduced into clinical practice.[1][2]
^Albrecht S, Hering W, Ihmsen H, Schwilden H, Schüttler J (October 1999). "[Pharmacokinetic-pharmacodynamic modeling in phase II of drug development. A comparative study with young and old volunteers with benzdiazepine as an example]". Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie. 34 (10): 634–7.
doi:
10.1055/s-1999-213.
PMID10548960.